Comorbidities in Chronic Obstructive Pulmonary Disease

Overview

Journal Proc Am Thorac Soc

Specialty Pulmonary Medicine

Date 2008 May 6

PMID 18453370

Citations 159

Authors

Wissam M Chatila

Byron M Thomashow

Omar A Minai

Gerard J Criner

Barry J Make

Affiliations

Soon will be listed here.

Abstract

Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and psychological disorders are commonly reported in patients with chronic obstructive pulmonary disease (COPD) but with great variability in reported prevalence. Tobacco smoking is a risk factor for many of these comorbidities as well as for COPD, making it difficult to draw conclusions about the relationship between COPD and these comorbidities. However, recent large epidemiologic studies have confirmed the independent detrimental effects of these comorbidities on patients with COPD. On the other hand, many of these comorbidities are now considered to be part of the commonly prevalent nonpulmonary sequelae of COPD that are relevant not only to the understanding of the real burden of COPD but also to the development of effective management strategies.

Citing Articles

Hematological Parameters Predicting Mortality in Patients with COPD Admitted to ICUs.

Alotaibi B, Alsabani M, Alghamdi A, Alotibi R, Al-Mutairi A, Philip W Saudi J Med Med Sci. 2025; 13(1):26-31.

PMID: 39935998 PMC: 11809761. DOI: 10.4103/sjmms.sjmms_276_24.

Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning.

Cao X, Ma J, He X, Liu Y, Yang Y, Wang Y BMC Med Inform Decis Mak. 2025; 25(1):50.

PMID: 39901185 PMC: 11792416. DOI: 10.1186/s12911-025-02885-0.

A two-sample mendelian randomization study of non-tuberculous mycobacteria infection and lung cancer.

Shen H, Yang M J Thorac Dis. 2025; 16(12):8472-8481.

PMID: 39831261 PMC: 11740078. DOI: 10.21037/jtd-24-1268.

Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline.

Saccomanno J, Kilic L, Sgarbossa T, Neumann K, Stanzel F, Holland A ERJ Open Res. 2025; 11(1.

PMID: 39811547 PMC: 11726540. DOI: 10.1183/23120541.00410-2024.

Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review.

Zailani H, Satyanarayanan S, Liao W, Su K, Chang J Curr Nutr Rep. 2025; 14(1):12.

PMID: 39760917 DOI: 10.1007/s13668-024-00599-9.

References

van Staa T, Leufkens H, Cooper C . The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002; 13(10):777-87. DOI: 10.1007/s001980200108. View

Malhotra S, Lam S, Paul Man S, Gan W, Sin D . The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and women. BMC Pulm Med. 2006; 6:2. PMC: 1373665. DOI: 10.1186/1471-2466-6-2. View

Sidney S, Sorel M, Quesenberry Jr C, DeLuise C, Lanes S, Eisner M . COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4):2068-75. DOI: 10.1378/chest.128.4.2068. View

Soriano J, Visick G, Muellerova H, Payvandi N, Hansell A . Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005; 128(4):2099-107. DOI: 10.1378/chest.128.4.2099. View

Hu F, Meigs J, Li T, Rifai N, Manson J . Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004; 53(3):693-700. DOI: 10.2337/diabetes.53.3.693. View

Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A . Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med. 2007; 101(10):2139-44. DOI: 10.1016/j.rmed.2007.05.011. View

Reid I . Osteoporosis--emerging consensus. Aust N Z J Med. 1998; 27(6):643-7. DOI: 10.1111/j.1445-5994.1997.tb00991.x. View

Halpern M, Zilberberg M, Schmier J, Lau E, Shorr A . Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc. 2006; 4:17. PMC: 1633732. DOI: 10.1186/1478-7547-4-17. View

Gluck O, Colice G . Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest. 2004; 125(5):1859-76. DOI: 10.1378/chest.125.5.1859. View

10.

Casanova C, Baudet J, Velasco M, Martin J, Aguirre-Jaime A, de Torres J . Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J. 2004; 23(6):841-5. DOI: 10.1183/09031936.04.00107004. View

11.

Mannino D . COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002; 121(5 Suppl):121S-126S. DOI: 10.1378/chest.121.5_suppl.121s. View

12.

Grundy S, Cleeman J, Merz C, Brewer Jr H, Clark L, Hunninghake D . Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004; 44(3):720-32. DOI: 10.1016/j.jacc.2004.07.001. View

13.

Craig W, Palomaki G, Haddow J . Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989; 298(6676):784-8. PMC: 1836079. DOI: 10.1136/bmj.298.6676.784. View

14.

Rana J, Mittleman M, Sheikh J, Hu F, Manson J, Colditz G . Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care. 2004; 27(10):2478-84. DOI: 10.2337/diacare.27.10.2478. View

15.

Patil S, Krishnan J, Lechtzin N, Diette G . In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003; 163(10):1180-6. DOI: 10.1001/archinte.163.10.1180. View

16.

Bolton C, Ionescu A, Shiels K, Pettit R, Edwards P, Stone M . Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 170(12):1286-93. DOI: 10.1164/rccm.200406-754OC. View

17.

Meehan T, Fine M, Krumholz H, Scinto J, Galusha D, Mockalis J . Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278(23):2080-4. View

18.

Mannino D, Brown C, Giovino G . Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997; 156(3 Pt 1):814-8. DOI: 10.1164/ajrccm.156.3.9702026. View

19.

Rimm E, Chan J, Stampfer M, Colditz G, Willett W . Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995; 310(6979):555-9. PMC: 2548937. DOI: 10.1136/bmj.310.6979.555. View

20.

Wise R, Connett J, Weinmann G, Scanlon P, Skeans M . Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 2001; 343(26):1902-9. DOI: 10.1056/NEJM200012283432601. View